PUBLISHER: Acute Market Reports | PRODUCT CODE: 1340086
PUBLISHER: Acute Market Reports | PRODUCT CODE: 1340086
Kyphoplasty Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031
The kyphoplasty market is expected to experience a CAGR of 5.5% during the forecast period of 2023 to 2031, driven by the rising prevalence of vertebral compression fractures (VCFs) and the growing aging population. Kyphoplasty is a minimally invasive surgical procedure used to treat VCFs, which are commonly caused by osteoporosis, trauma, or cancer. During the procedure, a balloon is inserted into the fractured vertebra and inflated to create a cavity. The cavity is then filled with bone cement, stabilizing the vertebra and relieving pain. The market revenue for Kyphoplasty has been increasing as the procedure gains popularity due to its effectiveness in providing pain relief and improving the quality of life for patients suffering from VCFs. The market is driven by several factors, including the rising geriatric population, which is more susceptible to VCFs due to age-related bone degeneration. Osteoporosis, a common condition among the elderly, further contributes to the increased incidence of vertebral compression fractures. Additionally, the growing awareness among healthcare professionals and patients about the benefits of Kyphoplasty in reducing pain and restoring vertebral height has fueled the demand for this procedure. Furthermore, advancements in medical technology and minimally invasive surgical techniques have led to improved Kyphoplasty procedures, resulting in shorter recovery times and reduced post-operative complications. These advancements have also made the procedure more accessible to a broader patient population, further driving market growth.
Growing Aging Population and Increasing Prevalence of Vertebral Compression Fractures
The Kyphoplasty market is driven by the growing aging population and the consequent rise in the prevalence of vertebral compression fractures (VCFs). As the global population ages, the incidence of osteoporosis and age-related bone degeneration increases. Osteoporosis weakens the bones, making them more susceptible to fractures, particularly in the vertebrae. According to a study published in the Journal of Bone and Mineral Research, the prevalence of VCFs is estimated to be 20-25% in women aged 50 and older. Additionally, with advancements in healthcare and improved life expectancy, the elderly population is projected to grow substantially in the coming years, further fueling the demand for Kyphoplasty procedures to treat VCFs.
Minimally Invasive Nature of Kyphoplasty and Improved Surgical Techniques
The minimally invasive nature of Kyphoplasty is a significant driver in the market's growth. Kyphoplasty is performed using small incisions, specialized instruments, and image-guided techniques, resulting in less tissue damage and reduced post-operative pain compared to traditional open surgeries. Patients undergoing Kyphoplasty often experience shorter hospital stays and faster recovery times, which contributes to enhanced patient satisfaction and reduced healthcare costs. A study published in the Journal of Orthopaedic Surgery and Research demonstrated that Kyphoplasty resulted in significantly lower intraoperative blood loss, reduced surgical time, and shorter hospital stays compared to traditional open surgery. The increasing adoption of minimally invasive techniques has attracted both patients and healthcare providers to Kyphoplasty as a preferred treatment option for VCFs.
Advancements in Medical Technology and Bone Cement Formulations
Advancements in medical technology and bone cement formulations have played a vital role in driving the Kyphoplasty market. The availability of modern imaging technologies, such as fluoroscopy and computed tomography (CT), enables precise visualization and guidance during the procedure, leading to improved surgical outcomes. Moreover, researchers and manufacturers have been continuously developing and refining bone cement formulations used in Kyphoplasty to enhance the stability and strength of vertebral augmentation. A study in the Journal of Orthopaedic Surgery and Research compared two types of bone cement used in Kyphoplasty and found that one cement formulation demonstrated superior biomechanical properties, indicating the potential for improved clinical outcomes. These advancements have not only made Kyphoplasty safer and more effective but have also expanded its applicability to a broader patient population, contributing to the market's overall growth.
Reimbursement and Cost Concerns
One significant restraint affecting the Kyphoplasty market is reimbursement and cost concerns. While Kyphoplasty is a clinically proven and effective procedure for treating vertebral compression fractures, reimbursement policies and varying coverage by insurance providers can create challenges for both patients and healthcare facilities. In some regions, the reimbursement rates for Kyphoplasty may not fully cover the procedure's costs, leading to financial burdens for patients and healthcare facilities alike. This can deter patients from opting for the procedure, particularly those without adequate insurance coverage or limited financial resources. Additionally, healthcare facilities may face financial constraints in providing Kyphoplasty services due to lower reimbursement rates, impacting their willingness to offer the procedure or invest in the necessary infrastructure and technologies. A study published in The Spine Journal highlighted that reimbursement policies and variations in coverage across different regions and insurance providers were significant barriers to the widespread adoption of Kyphoplasty. As a result, addressing reimbursement and cost concerns is crucial to ensuring equitable access to Kyphoplasty and sustaining market growth.
Spinal Fractures Dominates the Market by Application
The Kyphoplasty market is segmented based on application into three main categories: Vertebral Alignment Restoration, Spinal Fractures, and Kyphosis. Currently, the Spinal Fractures segment held the highest revenue share in the market in 2022. Spinal fractures, often caused by osteoporosis, trauma, or cancer, lead to vertebral compression fractures (VCFs) that result in pain, deformity, and loss of vertebral height. Kyphoplasty is highly effective in treating spinal fractures by restoring vertebral height, stabilizing the fractured vertebrae, and providing pain relief. As a result, the demand for Kyphoplasty procedures to address spinal fractures has been consistently high. However, it is the Kyphosis segment is expected to exhibit the highest CAGR in the Kyphoplasty market during the forecast period of 2023 to 2031. Kyphosis refers to an excessive curvature of the spine, leading to a forward-bending posture and often causing back pain and functional impairment. Kyphoplasty has emerged as a valuable treatment option for selected cases of kyphosis, particularly those related to osteoporotic vertebral fractures. The procedure aims to correct the abnormal spinal curvature and restore vertebral alignment, resulting in improved spinal balance and patient mobility. As awareness of the benefits of Kyphoplasty for kyphosis increases, coupled with advancements in surgical techniques and medical technology, the Kyphosis segment is expected to witness significant growth in the coming years.
Osteoporosis Segment Dominates the Market by Indication
The Kyphoplasty market is segmented based on indication into two main categories: Osteoporosis and Others. The osteoporosis segment held the highest revenue share in the market in 2022. Osteoporosis is a prevalent condition characterized by low bone density and increased bone fragility, leading to a higher risk of vertebral compression fractures (VCFs). Kyphoplasty is widely used as a minimally invasive and effective procedure to treat VCFs associated with osteoporosis, providing pain relief, restoring vertebral height, and stabilizing the fractured vertebrae. As the aging population grows and osteoporosis becomes more prevalent, the demand for Kyphoplasty to address osteoporotic VCFs is expected to remain dominant in the market. However, it is the other segment that exhibits the highest CAGR in the Kyphoplasty market during the forecast period of 2023 to 2031. The Others segment includes indications for Kyphoplasty beyond osteoporosis, such as traumatic vertebral fractures and fractures caused by cancer metastases. Traumatic fractures result from accidents or injuries, while cancer metastases to the spine and can lead to weakened vertebrae and compression fractures. Kyphoplasty offers a valuable treatment option for these indications, helping to relieve pain and improve patient mobility. As awareness of the benefits of Kyphoplasty for non-osteoporotic indications increases, coupled with advances in medical technology and expanded clinical applications, the others segment is expected to witness significant growth in the foreseeable future.
North America Remains as the Global Leader
North America held the highest revenue percentage in the market in 2022, driven by well-established healthcare infrastructure, increasing prevalence of osteoporosis-related vertebral compression fractures (VCFs), and the availability of advanced medical technologies. Additionally, growing awareness among healthcare professionals and patients about the benefits of Kyphoplasty has contributed to the region's dominant market position. Europe closely follows North America in terms of revenue, with a significant patient pool and a strong focus on improving patient outcomes and quality of life. However, it is the Asia-Pacific region that exhibits the highest CAGR during the forecast period of 2023 to 2031 in the Kyphoplasty market. The Asia-Pacific region is experiencing substantial growth due to factors such as a large aging population, increasing prevalence of osteoporosis, and rising awareness of advanced medical procedures. Countries like China, India, and Japan are witnessing a surge in demand for Kyphoplasty procedures as the incidence of osteoporosis-related VCFs rises with the aging population. Moreover, the region's healthcare systems are continuously evolving, and investments in healthcare infrastructure and medical technology are driving the adoption of Kyphoplasty to address spinal disorders. Latin America and the Middle East & Africa (MEA) regions also contribute to the Kyphoplasty market. In Latin America, improving healthcare access and rising awareness of minimally invasive procedures have bolstered the demand for Kyphoplasty. The MEA region is witnessing growing investments in healthcare infrastructure and increased availability of specialized medical services, leading to the rising adoption of Kyphoplasty.
Market Competition to Intensify during the Forecast Period
The Kyphoplasty market is highly competitive, with several key players vying for market share. Some of the top players in the market include Medtronic plc, Stryker Corporation, DePuy Synthes (Johnson & Johnson), Globus Medical Inc., and Merit Medical Systems Inc., among others. These companies dominate the Kyphoplasty market by offering a wide range of Kyphoplasty products and related services, establishing a strong global presence, and adopting various key strategies to maintain their competitive edge. One of the key competitive trends in the Kyphoplasty market is product innovation and development. Leading players invest significantly in research and development to introduce advanced Kyphoplasty systems and technologies. These innovations aim to improve overall procedural outcomes, enhance patient safety, and reduce the risk of complications. For instance, companies have introduced balloon kyphoplasty systems with enhanced bone cement delivery mechanisms and improved imaging technologies for precise vertebral augmentation. By continuously advancing their product offerings, these companies seek to attract healthcare providers and gain a competitive advantage in the market. Strategic partnerships and collaborations are also prominent in the Kyphoplasty market. Top players often collaborate with other medical device manufacturers, healthcare institutions, and research organizations to expand their product portfolio and market reach. Such collaborations facilitate the exchange of knowledge, expertise, and resources, enabling companies to offer comprehensive solutions for spinal disorders and strengthen their market position. For instance, partnerships with healthcare facilities help companies demonstrate the clinical benefits of their Kyphoplasty products and enhance the adoption of these procedures among physicians and patients. Additionally, market players focus on geographical expansions to tap into emerging markets and diversify their customer base. Establishing a strong presence in regions with a growing geriatric population and a rising prevalence of osteoporosis-related vertebral compression fractures allows these companies to cater to the specific needs of local patient populations. Expanding distribution networks and investing in marketing and promotional activities enable them to capture a larger share of the Kyphoplasty market in these regions.
Historical & Forecast Period
This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation ofKyphoplasty market are as follows:
Research and development budgets of manufacturers and government spending
Revenues of key companies in the market segment
Number of end users and consumption volume, price and value.
Geographical revenues generate by countries considered in the report
Micro and macro environment factors that are currently influencing the Kyphoplasty market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
Market Segmentation
Product
Balloon Catheters
Bone Access Devices
Cement Application Products
Bone Cement
Cement Mixing Systems
Instruments
Application
Vertebral Alignment Restoration
Spinal Fractures
Kyphosis
Indication
Osteoporosis
Others
End-Use
Hospitals & Clinics
Ambulatory Surgical Centers
Region Segment (2021-2031; US$ Million)
North America
U.S.
Canada
Rest of North America
UK and European Union
UK
Germany
Spain
Italy
France
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa
GCC
Africa
Rest of Middle East and Africa
Key questions answered in this report
What are the key micro and macro environmental factors that are impacting the growth of Kyphoplasty market?
What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
Estimated forecast and market projections up to 2031.
Which segment accounts for the fastest CAGR during the forecast period?
Which market segment holds a larger market share and why?
Are low and middle-income economies investing in the Kyphoplasty market?
Which is the largest regional market for Kyphoplasty market?
What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
Which are the key trends driving Kyphoplasty market growth?
Who are the key competitors and what are their key strategies to enhance their market presence in the Kyphoplasty market worldwide?
Table of Contents
1. Preface
- 1.1. Report Description
- 1.1.1. Purpose of the Report
- 1.1.2. Target Audience
- 1.1.3. Key Offerings
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.3.1. Phase I - Secondary Research
- 1.3.2. Phase II - Primary Research
- 1.3.3. Phase III - Expert Panel Review
- 1.3.4. Assumptions
- 1.3.5. Approach Adopted
2. Executive Summary
- 2.1. Market Snapshot: Global Kyphoplasty Market
- 2.2. Global Kyphoplasty Market, By Product, 2022 (US$ Million)
- 2.3. Global Kyphoplasty Market, By Application, 2022 (US$ Million)
- 2.4. Global Kyphoplasty Market, By Indication, 2022 (US$ Million)
- 2.5. Global Kyphoplasty Market, By End-Use, 2022 (US$ Million)
- 2.6. Global Kyphoplasty Market, By Geography, 2022 (US$ Million)
- 2.7. Attractive Investment Proposition by Geography, 2022
3. Kyphoplasty Market: Competitive Analysis
- 3.1. Market Positioning of Key Kyphoplasty Market Vendors
- 3.2. Strategies Adopted by Kyphoplasty Market Vendors
- 3.3. Key Industry Strategies
- 3.4. Tier Analysis 2022 Versus 2031
4. Kyphoplasty Market: Macro Analysis & Market Dynamics
- 4.1. Introduction
- 4.2. Global Kyphoplasty Market Value, 2021 - 2031, (US$ Million)
- 4.3. Market Dynamics
- 4.3.1. Market Drivers
- 4.3.2. Market Restraints
- 4.3.3. Key Challenges
- 4.3.4. Key Opportunities
- 4.4. Impact Analysis of Drivers and Restraints
- 4.5. See-Saw Analysis
5. Kyphoplasty Market: By Product, 2021-2031, USD (Million)
- 5.1. Market Overview
- 5.2. Growth & Revenue Analysis: 2022 Versus 2031
- 5.3. Market Segmentation
- 5.3.1. Balloon Catheters
- 5.3.2. Bone Access Devices
- 5.3.3. Cement Application Products
- 5.3.4. Bone Cement
- 5.3.5. Cement Mixing Systems
- 5.3.6. Instruments
6. Kyphoplasty Market: By Application, 2021-2031, USD (Million)
- 6.1. Market Overview
- 6.2. Growth & Revenue Analysis: 2022 Versus 2031
- 6.3. Market Segmentation
- 6.3.1. Vertebral Alignment Restoration
- 6.3.2. Spinal Fractures
- 6.3.3. Kyphosis
7. Kyphoplasty Market: By Indication, 2021-2031, USD (Million)
- 7.1. Market Overview
- 7.2. Growth & Revenue Analysis: 2022 Versus 2031
- 7.3. Market Segmentation
- 7.3.1. Osteoporosis
- 7.3.2. Others
8. Kyphoplasty Market: By End-Use, 2021-2031, USD (Million)
- 8.1. Market Overview
- 8.2. Growth & Revenue Analysis: 2022 Versus 2031
- 8.3. Market Segmentation
- 8.3.1. Hospitals & Clinics
- 8.3.2. Ambulatory Surgical Centers
9. North America Kyphoplasty Market, 2021-2031, USD (Million)
- 9.1. Market Overview
- 9.2. Kyphoplasty Market: By Product, 2021-2031, USD (Million)
- 9.3. Kyphoplasty Market: By Application, 2021-2031, USD (Million)
- 9.4. Kyphoplasty Market: By Indication, 2021-2031, USD (Million)
- 9.5. Kyphoplasty Market: By End-Use, 2021-2031, USD (Million)
- 9.6.Kyphoplasty Market: By Region, 2021-2031, USD (Million)
- 9.6.1.North America
- 9.6.1.1. U.S.
- 9.6.1.1.1. Kyphoplasty Market: By Product, 2021-2031, USD (Million)
- 9.6.1.1.2. Kyphoplasty Market: By Application, 2021-2031, USD (Million)
- 9.6.1.1.3. Kyphoplasty Market: By Indication, 2021-2031, USD (Million)
- 9.6.1.1.4. Kyphoplasty Market: By End-Use, 2021-2031, USD (Million)
- 9.6.1.2. Canada
- 9.6.1.2.1. Kyphoplasty Market: By Product, 2021-2031, USD (Million)
- 9.6.1.2.2. Kyphoplasty Market: By Application, 2021-2031, USD (Million)
- 9.6.1.2.3. Kyphoplasty Market: By Indication, 2021-2031, USD (Million)
- 9.6.1.2.4. Kyphoplasty Market: By End-Use, 2021-2031, USD (Million)
- 9.6.1.3. Rest of North America
- 9.6.1.3.1. Kyphoplasty Market: By Product, 2021-2031, USD (Million)
- 9.6.1.3.2. Kyphoplasty Market: By Application, 2021-2031, USD (Million)
- 9.6.1.3.3. Kyphoplasty Market: By Indication, 2021-2031, USD (Million)
- 9.6.1.3.4. Kyphoplasty Market: By End-Use, 2021-2031, USD (Million)
- 9.6.1.1. U.S.
- 9.6.1.North America
10. UK and European Union Kyphoplasty Market, 2021-2031, USD (Million)
- 10.1. Market Overview
- 10.2. Kyphoplasty Market: By Product, 2021-2031, USD (Million)
- 10.3. Kyphoplasty Market: By Application, 2021-2031, USD (Million)
- 10.4. Kyphoplasty Market: By Indication, 2021-2031, USD (Million)
- 10.5. Kyphoplasty Market: By End-Use, 2021-2031, USD (Million)
- 10.6.Kyphoplasty Market: By Region, 2021-2031, USD (Million)
- 10.6.1.UK and European Union
- 10.6.1.1. UK
- 10.6.1.1.1. Kyphoplasty Market: By Product, 2021-2031, USD (Million)
- 10.6.1.1.2. Kyphoplasty Market: By Application, 2021-2031, USD (Million)
- 10.6.1.1.3. Kyphoplasty Market: By Indication, 2021-2031, USD (Million)
- 10.6.1.1.4. Kyphoplasty Market: By End-Use, 2021-2031, USD (Million)
- 10.6.1.2. Germany
- 10.6.1.2.1. Kyphoplasty Market: By Product, 2021-2031, USD (Million)
- 10.6.1.2.2. Kyphoplasty Market: By Application, 2021-2031, USD (Million)
- 10.6.1.2.3. Kyphoplasty Market: By Indication, 2021-2031, USD (Million)
- 10.6.1.2.4. Kyphoplasty Market: By End-Use, 2021-2031, USD (Million)
- 10.6.1.3. Spain
- 10.6.1.3.1. Kyphoplasty Market: By Product, 2021-2031, USD (Million)
- 10.6.1.3.2. Kyphoplasty Market: By Application, 2021-2031, USD (Million)
- 10.6.1.3.3. Kyphoplasty Market: By Indication, 2021-2031, USD (Million)
- 10.6.1.3.4. Kyphoplasty Market: By End-Use, 2021-2031, USD (Million)
- 10.6.1.4. Italy
- 10.6.1.4.1. Kyphoplasty Market: By Product, 2021-2031, USD (Million)
- 10.6.1.4.2. Kyphoplasty Market: By Application, 2021-2031, USD (Million)
- 10.6.1.4.3. Kyphoplasty Market: By Indication, 2021-2031, USD (Million)
- 10.6.1.4.4. Kyphoplasty Market: By End-Use, 2021-2031, USD (Million)
- 10.6.1.5. France
- 10.6.1.5.1. Kyphoplasty Market: By Product, 2021-2031, USD (Million)
- 10.6.1.5.2. Kyphoplasty Market: By Application, 2021-2031, USD (Million)
- 10.6.1.5.3. Kyphoplasty Market: By Indication, 2021-2031, USD (Million)
- 10.6.1.5.4. Kyphoplasty Market: By End-Use, 2021-2031, USD (Million)
- 10.6.1.6. Rest of Europe
- 10.6.1.6.1. Kyphoplasty Market: By Product, 2021-2031, USD (Million)
- 10.6.1.6.2. Kyphoplasty Market: By Application, 2021-2031, USD (Million)
- 10.6.1.6.3. Kyphoplasty Market: By Indication, 2021-2031, USD (Million)
- 10.6.1.6.4. Kyphoplasty Market: By End-Use, 2021-2031, USD (Million)
- 10.6.1.1. UK
- 10.6.1.UK and European Union
11. Asia Pacific Kyphoplasty Market, 2021-2031, USD (Million)
- 11.1. Market Overview
- 11.2. Kyphoplasty Market: By Product, 2021-2031, USD (Million)
- 11.3. Kyphoplasty Market: By Application, 2021-2031, USD (Million)
- 11.4. Kyphoplasty Market: By Indication, 2021-2031, USD (Million)
- 11.5. Kyphoplasty Market: By End-Use, 2021-2031, USD (Million)
- 11.6.Kyphoplasty Market: By Region, 2021-2031, USD (Million)
- 11.6.1.Asia Pacific
- 11.6.1.1. China
- 11.6.1.1.1. Kyphoplasty Market: By Product, 2021-2031, USD (Million)
- 11.6.1.1.2. Kyphoplasty Market: By Application, 2021-2031, USD (Million)
- 11.6.1.1.3. Kyphoplasty Market: By Indication, 2021-2031, USD (Million)
- 11.6.1.1.4. Kyphoplasty Market: By End-Use, 2021-2031, USD (Million)
- 11.6.1.2. Japan
- 11.6.1.2.1. Kyphoplasty Market: By Product, 2021-2031, USD (Million)
- 11.6.1.2.2. Kyphoplasty Market: By Application, 2021-2031, USD (Million)
- 11.6.1.2.3. Kyphoplasty Market: By Indication, 2021-2031, USD (Million)
- 11.6.1.2.4. Kyphoplasty Market: By End-Use, 2021-2031, USD (Million)
- 11.6.1.3. India
- 11.6.1.3.1. Kyphoplasty Market: By Product, 2021-2031, USD (Million)
- 11.6.1.3.2. Kyphoplasty Market: By Application, 2021-2031, USD (Million)
- 11.6.1.3.3. Kyphoplasty Market: By Indication, 2021-2031, USD (Million)
- 11.6.1.3.4. Kyphoplasty Market: By End-Use, 2021-2031, USD (Million)
- 11.6.1.4. Australia
- 11.6.1.4.1. Kyphoplasty Market: By Product, 2021-2031, USD (Million)
- 11.6.1.4.2. Kyphoplasty Market: By Application, 2021-2031, USD (Million)
- 11.6.1.4.3. Kyphoplasty Market: By Indication, 2021-2031, USD (Million)
- 11.6.1.4.4. Kyphoplasty Market: By End-Use, 2021-2031, USD (Million)
- 11.6.1.5. South Korea
- 11.6.1.5.1. Kyphoplasty Market: By Product, 2021-2031, USD (Million)
- 11.6.1.5.2. Kyphoplasty Market: By Application, 2021-2031, USD (Million)
- 11.6.1.5.3. Kyphoplasty Market: By Indication, 2021-2031, USD (Million)
- 11.6.1.5.4. Kyphoplasty Market: By End-Use, 2021-2031, USD (Million)
- 11.6.1.6. Rest of Asia Pacific
- 11.6.1.6.1. Kyphoplasty Market: By Product, 2021-2031, USD (Million)
- 11.6.1.6.2. Kyphoplasty Market: By Application, 2021-2031, USD (Million)
- 11.6.1.6.3. Kyphoplasty Market: By Indication, 2021-2031, USD (Million)
- 11.6.1.6.4. Kyphoplasty Market: By End-Use, 2021-2031, USD (Million)
- 11.6.1.1. China
- 11.6.1.Asia Pacific
12. Latin America Kyphoplasty Market, 2021-2031, USD (Million)
- 12.1. Market Overview
- 12.2. Kyphoplasty Market: By Product, 2021-2031, USD (Million)
- 12.3. Kyphoplasty Market: By Application, 2021-2031, USD (Million)
- 12.4. Kyphoplasty Market: By Indication, 2021-2031, USD (Million)
- 12.5. Kyphoplasty Market: By End-Use, 2021-2031, USD (Million)
- 12.6.Kyphoplasty Market: By Region, 2021-2031, USD (Million)
- 12.6.1.Latin America
- 12.6.1.1. Brazil
- 12.6.1.1.1. Kyphoplasty Market: By Product, 2021-2031, USD (Million)
- 12.6.1.1.2. Kyphoplasty Market: By Application, 2021-2031, USD (Million)
- 12.6.1.1.3. Kyphoplasty Market: By Indication, 2021-2031, USD (Million)
- 12.6.1.1.4. Kyphoplasty Market: By End-Use, 2021-2031, USD (Million)
- 12.6.1.2. Mexico
- 12.6.1.2.1. Kyphoplasty Market: By Product, 2021-2031, USD (Million)
- 12.6.1.2.2. Kyphoplasty Market: By Application, 2021-2031, USD (Million)
- 12.6.1.2.3. Kyphoplasty Market: By Indication, 2021-2031, USD (Million)
- 12.6.1.2.4. Kyphoplasty Market: By End-Use, 2021-2031, USD (Million)
- 12.6.1.3. Rest of Latin America
- 12.6.1.3.1. Kyphoplasty Market: By Product, 2021-2031, USD (Million)
- 12.6.1.3.2. Kyphoplasty Market: By Application, 2021-2031, USD (Million)
- 12.6.1.3.3. Kyphoplasty Market: By Indication, 2021-2031, USD (Million)
- 12.6.1.3.4. Kyphoplasty Market: By End-Use, 2021-2031, USD (Million)
- 12.6.1.1. Brazil
- 12.6.1.Latin America
13. Middle East and Africa Kyphoplasty Market, 2021-2031, USD (Million)
- 13.1. Market Overview
- 13.2. Kyphoplasty Market: By Product, 2021-2031, USD (Million)
- 13.3. Kyphoplasty Market: By Application, 2021-2031, USD (Million)
- 13.4. Kyphoplasty Market: By Indication, 2021-2031, USD (Million)
- 13.5. Kyphoplasty Market: By End-Use, 2021-2031, USD (Million)
- 13.6.Kyphoplasty Market: By Region, 2021-2031, USD (Million)
- 13.6.1.Middle East and Africa
- 13.6.1.1. GCC
- 13.6.1.1.1. Kyphoplasty Market: By Product, 2021-2031, USD (Million)
- 13.6.1.1.2. Kyphoplasty Market: By Application, 2021-2031, USD (Million)
- 13.6.1.1.3. Kyphoplasty Market: By Indication, 2021-2031, USD (Million)
- 13.6.1.1.4. Kyphoplasty Market: By End-Use, 2021-2031, USD (Million)
- 13.6.1.2. Africa
- 13.6.1.2.1. Kyphoplasty Market: By Product, 2021-2031, USD (Million)
- 13.6.1.2.2. Kyphoplasty Market: By Application, 2021-2031, USD (Million)
- 13.6.1.2.3. Kyphoplasty Market: By Indication, 2021-2031, USD (Million)
- 13.6.1.2.4. Kyphoplasty Market: By End-Use, 2021-2031, USD (Million)
- 13.6.1.3. Rest of Middle East and Africa
- 13.6.1.3.1. Kyphoplasty Market: By Product, 2021-2031, USD (Million)
- 13.6.1.3.2. Kyphoplasty Market: By Application, 2021-2031, USD (Million)
- 13.6.1.3.3. Kyphoplasty Market: By Indication, 2021-2031, USD (Million)
- 13.6.1.3.4. Kyphoplasty Market: By End-Use, 2021-2031, USD (Million)
- 13.6.1.1. GCC
- 13.6.1.Middle East and Africa
14. Company Profile
- 14.1. Medtronic plc
- 14.1.1. Company Overview
- 14.1.2. Financial Performance
- 14.1.3. Product Portfolio
- 14.1.4. Strategic Initiatives
- 14.2. Stryker Corporation
- 14.2.1. Company Overview
- 14.2.2. Financial Performance
- 14.2.3. Product Portfolio
- 14.2.4. Strategic Initiatives
- 14.3. DePuy Synthes (Johnson & Johnson)
- 14.3.1. Company Overview
- 14.3.2. Financial Performance
- 14.3.3. Product Portfolio
- 14.3.4. Strategic Initiatives
- 14.4. Globus Medical Inc.
- 14.4.1. Company Overview
- 14.4.2. Financial Performance
- 14.4.3. Product Portfolio
- 14.4.4. Strategic Initiatives
- 14.5. Merit Medical Systems Inc
- 14.5.1. Company Overview
- 14.5.2. Financial Performance
- 14.5.3. Product Portfolio
- 14.5.4. Strategic Initiatives
- 14.6. Other Notable Players
- 14.6.1. Company Overview
- 14.6.2. Financial Performance
- 14.6.3. Product Portfolio
- 14.6.4. Strategic Initiatives
List of Tables
- TABLE 1 Global Kyphoplasty Market By Product, 2021-2031, USD (Million)
- TABLE 2 Global Kyphoplasty Market By Application, 2021-2031, USD (Million)
- TABLE 3 Global Kyphoplasty Market By Indication, 2021-2031, USD (Million)
- TABLE 4 Global Kyphoplasty Market By End-Use, 2021-2031, USD (Million)
- TABLE 5 North America Kyphoplasty Market By Product, 2021-2031, USD (Million)
- TABLE 6 North America Kyphoplasty Market By Application, 2021-2031, USD (Million)
- TABLE 7 North America Kyphoplasty Market By Indication, 2021-2031, USD (Million)
- TABLE 8 North America Kyphoplasty Market By End-Use, 2021-2031, USD (Million)
- TABLE 9 U.S. Kyphoplasty Market By Product, 2021-2031, USD (Million)
- TABLE 10 U.S. Kyphoplasty Market By Application, 2021-2031, USD (Million)
- TABLE 11 U.S. Kyphoplasty Market By Indication, 2021-2031, USD (Million)
- TABLE 12 U.S. Kyphoplasty Market By End-Use, 2021-2031, USD (Million)
- TABLE 13 Canada Kyphoplasty Market By Product, 2021-2031, USD (Million)
- TABLE 14 Canada Kyphoplasty Market By Application, 2021-2031, USD (Million)
- TABLE 15 Canada Kyphoplasty Market By Indication, 2021-2031, USD (Million)
- TABLE 16 Canada Kyphoplasty Market By End-Use, 2021-2031, USD (Million)
- TABLE 17 Rest of North America Kyphoplasty Market By Product, 2021-2031, USD (Million)
- TABLE 18 Rest of North America Kyphoplasty Market By Application, 2021-2031, USD (Million)
- TABLE 19 Rest of North America Kyphoplasty Market By Indication, 2021-2031, USD (Million)
- TABLE 20 Rest of North America Kyphoplasty Market By End-Use, 2021-2031, USD (Million)
- TABLE 21 UK and European Union Kyphoplasty Market By Product, 2021-2031, USD (Million)
- TABLE 22 UK and European Union Kyphoplasty Market By Application, 2021-2031, USD (Million)
- TABLE 23 UK and European Union Kyphoplasty Market By Indication, 2021-2031, USD (Million)
- TABLE 24 UK and European Union Kyphoplasty Market By End-Use, 2021-2031, USD (Million)
- TABLE 25 UK Kyphoplasty Market By Product, 2021-2031, USD (Million)
- TABLE 26 UK Kyphoplasty Market By Application, 2021-2031, USD (Million)
- TABLE 27 UK Kyphoplasty Market By Indication, 2021-2031, USD (Million)
- TABLE 28 UK Kyphoplasty Market By End-Use, 2021-2031, USD (Million)
- TABLE 29 Germany Kyphoplasty Market By Product, 2021-2031, USD (Million)
- TABLE 30 Germany Kyphoplasty Market By Application, 2021-2031, USD (Million)
- TABLE 31 Germany Kyphoplasty Market By Indication, 2021-2031, USD (Million)
- TABLE 32 Germany Kyphoplasty Market By End-Use, 2021-2031, USD (Million)
- TABLE 33 Spain Kyphoplasty Market By Product, 2021-2031, USD (Million)
- TABLE 34 Spain Kyphoplasty Market By Application, 2021-2031, USD (Million)
- TABLE 35 Spain Kyphoplasty Market By Indication, 2021-2031, USD (Million)
- TABLE 36 Spain Kyphoplasty Market By End-Use, 2021-2031, USD (Million)
- TABLE 37 Italy Kyphoplasty Market By Product, 2021-2031, USD (Million)
- TABLE 38 Italy Kyphoplasty Market By Application, 2021-2031, USD (Million)
- TABLE 39 Italy Kyphoplasty Market By Indication, 2021-2031, USD (Million)
- TABLE 40 Italy Kyphoplasty Market By End-Use, 2021-2031, USD (Million)
- TABLE 41 France Kyphoplasty Market By Product, 2021-2031, USD (Million)
- TABLE 42 France Kyphoplasty Market By Application, 2021-2031, USD (Million)
- TABLE 43 France Kyphoplasty Market By Indication, 2021-2031, USD (Million)
- TABLE 44 France Kyphoplasty Market By End-Use, 2021-2031, USD (Million)
- TABLE 45 Rest of Europe Kyphoplasty Market By Product, 2021-2031, USD (Million)
- TABLE 46 Rest of Europe Kyphoplasty Market By Application, 2021-2031, USD (Million)
- TABLE 47 Rest of Europe Kyphoplasty Market By Indication, 2021-2031, USD (Million)
- TABLE 48 Rest of Europe Kyphoplasty Market By End-Use, 2021-2031, USD (Million)
- TABLE 49 Asia Kyphoplasty Market By Product, 2021-2031, USD (Million)
- TABLE 50 Asia Kyphoplasty Market By Application, 2021-2031, USD (Million)
- TABLE 51 Asia Kyphoplasty Market By Indication, 2021-2031, USD (Million)
- TABLE 52 Asia Kyphoplasty Market By End-Use, 2021-2031, USD (Million)
- TABLE 53 China Kyphoplasty Market By Product, 2021-2031, USD (Million)
- TABLE 54 China Kyphoplasty Market By Application, 2021-2031, USD (Million)
- TABLE 55 China Kyphoplasty Market By Indication, 2021-2031, USD (Million)
- TABLE 56 China Kyphoplasty Market By End-Use, 2021-2031, USD (Million)
- TABLE 57 Japan Kyphoplasty Market By Product, 2021-2031, USD (Million)
- TABLE 58 Japan Kyphoplasty Market By Application, 2021-2031, USD (Million)
- TABLE 59 Japan Kyphoplasty Market By Indication, 2021-2031, USD (Million)
- TABLE 60 Japan Kyphoplasty Market By End-Use, 2021-2031, USD (Million)
- TABLE 61 India Kyphoplasty Market By Product, 2021-2031, USD (Million)
- TABLE 62 India Kyphoplasty Market By Application, 2021-2031, USD (Million)
- TABLE 63 India Kyphoplasty Market By Indication, 2021-2031, USD (Million)
- TABLE 64 India Kyphoplasty Market By End-Use, 2021-2031, USD (Million)
- TABLE 65 Australia Kyphoplasty Market By Product, 2021-2031, USD (Million)
- TABLE 66 Australia Kyphoplasty Market By Application, 2021-2031, USD (Million)
- TABLE 67 Australia Kyphoplasty Market By Indication, 2021-2031, USD (Million)
- TABLE 68 Australia Kyphoplasty Market By End-Use, 2021-2031, USD (Million)
- TABLE 69 South Korea Kyphoplasty Market By Product, 2021-2031, USD (Million)
- TABLE 70 South Korea Kyphoplasty Market By Application, 2021-2031, USD (Million)
- TABLE 71 South Korea Kyphoplasty Market By Indication, 2021-2031, USD (Million)
- TABLE 72 South Korea Kyphoplasty Market By End-Use, 2021-2031, USD (Million)
- TABLE 73 Latin America Kyphoplasty Market By Product, 2021-2031, USD (Million)
- TABLE 74 Latin America Kyphoplasty Market By Application, 2021-2031, USD (Million)
- TABLE 75 Latin America Kyphoplasty Market By Indication, 2021-2031, USD (Million)
- TABLE 76 Latin America Kyphoplasty Market By End-Use, 2021-2031, USD (Million)
- TABLE 77 Brazil Kyphoplasty Market By Product, 2021-2031, USD (Million)
- TABLE 78 Brazil Kyphoplasty Market By Application, 2021-2031, USD (Million)
- TABLE 79 Brazil Kyphoplasty Market By Indication, 2021-2031, USD (Million)
- TABLE 80 Brazil Kyphoplasty Market By End-Use, 2021-2031, USD (Million)
- TABLE 81 Mexico Kyphoplasty Market By Product, 2021-2031, USD (Million)
- TABLE 82 Mexico Kyphoplasty Market By Application, 2021-2031, USD (Million)
- TABLE 83 Mexico Kyphoplasty Market By Indication, 2021-2031, USD (Million)
- TABLE 84 Mexico Kyphoplasty Market By End-Use, 2021-2031, USD (Million)
- TABLE 85 Rest of Latin America Kyphoplasty Market By Product, 2021-2031, USD (Million)
- TABLE 86 Rest of Latin America Kyphoplasty Market By Application, 2021-2031, USD (Million)
- TABLE 87 Rest of Latin America Kyphoplasty Market By Indication, 2021-2031, USD (Million)
- TABLE 88 Rest of Latin America Kyphoplasty Market By End-Use, 2021-2031, USD (Million)
- TABLE 89 Middle East and Africa Kyphoplasty Market By Product, 2021-2031, USD (Million)
- TABLE 90 Middle East and Africa Kyphoplasty Market By Application, 2021-2031, USD (Million)
- TABLE 91 Middle East and Africa Kyphoplasty Market By Indication, 2021-2031, USD (Million)
- TABLE 92 Middle East and Africa Kyphoplasty Market By End-Use, 2021-2031, USD (Million)
- TABLE 93 GCC Kyphoplasty Market By Product, 2021-2031, USD (Million)
- TABLE 94 GCC Kyphoplasty Market By Application, 2021-2031, USD (Million)
- TABLE 95 GCC Kyphoplasty Market By Indication, 2021-2031, USD (Million)
- TABLE 96 GCC Kyphoplasty Market By End-Use, 2021-2031, USD (Million)
- TABLE 97 Africa Kyphoplasty Market By Product, 2021-2031, USD (Million)
- TABLE 98 Africa Kyphoplasty Market By Application, 2021-2031, USD (Million)
- TABLE 99 Africa Kyphoplasty Market By Indication, 2021-2031, USD (Million)
- TABLE 100 Africa Kyphoplasty Market By End-Use, 2021-2031, USD (Million)
- TABLE 101 Rest of Middle East and Africa Kyphoplasty Market By Product, 2021-2031, USD (Million)
- TABLE 102 Rest of Middle East and Africa Kyphoplasty Market By Application, 2021-2031, USD (Million)
- TABLE 103 Rest of Middle East and Africa Kyphoplasty Market By Indication, 2021-2031, USD (Million)
- TABLE 104 Rest of Middle East and Africa Kyphoplasty Market By End-Use, 2021-2031, USD (Million)
List of Figures
- FIG. 1 Global Kyphoplasty Market: Market Coverage
- FIG. 2 Research Methodology and Data Sources
- FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
- FIG. 4 Global Kyphoplasty Market: Quality Assurance
- FIG. 5 Global Kyphoplasty Market, By Product, 2022
- FIG. 6 Global Kyphoplasty Market, By Application, 2022
- FIG. 7 Global Kyphoplasty Market, By Indication, 2022
- FIG. 8 Global Kyphoplasty Market, By End-Use, 2022
- FIG. 9 Global Kyphoplasty Market, By Geography, 2022
- FIG. 10 Market Geographical Opportunity Matrix - Global Kyphoplasty Market, 2022
FIG. 11Market Positioning of Key Kyphoplasty Market Players, 2022
FIG. 12Global Kyphoplasty Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
- FIG. 13 Global Kyphoplasty Market, By Product, 2022 Vs 2031, %
- FIG. 14 Global Kyphoplasty Market, By Application, 2022 Vs 2031, %
- FIG. 15 Global Kyphoplasty Market, By Indication, 2022 Vs 2031, %
- FIG. 16 Global Kyphoplasty Market, By End-Use, 2022 Vs 2031, %
- FIG. 17 U.S. Kyphoplasty Market (US$ Million), 2021 - 2031
- FIG. 18 Canada Kyphoplasty Market (US$ Million), 2021 - 2031
- FIG. 19 Rest of North America Kyphoplasty Market (US$ Million), 2021 - 2031
- FIG. 20 UK Kyphoplasty Market (US$ Million), 2021 - 2031
- FIG. 21 Germany Kyphoplasty Market (US$ Million), 2021 - 2031
- FIG. 22 Spain Kyphoplasty Market (US$ Million), 2021 - 2031
- FIG. 23 Italy Kyphoplasty Market (US$ Million), 2021 - 2031
- FIG. 24 France Kyphoplasty Market (US$ Million), 2021 - 2031
- FIG. 25 Rest of Europe Kyphoplasty Market (US$ Million), 2021 - 2031
- FIG. 26 China Kyphoplasty Market (US$ Million), 2021 - 2031
- FIG. 27 Japan Kyphoplasty Market (US$ Million), 2021 - 2031
- FIG. 28 India Kyphoplasty Market (US$ Million), 2021 - 2031
- FIG. 29 Australia Kyphoplasty Market (US$ Million), 2021 - 2031
- FIG. 30 South Korea Kyphoplasty Market (US$ Million), 2021 - 2031
- FIG. 31 Rest of Asia Kyphoplasty Market (US$ Million), 2021 - 2031
- FIG. 32 Brazil Kyphoplasty Market (US$ Million), 2021 - 2031
- FIG. 33 Mexico Kyphoplasty Market (US$ Million), 2021 - 2031
- FIG. 34 Rest of Latin America Kyphoplasty Market (US$ Million), 2021 - 2031
- FIG. 35 GCC Kyphoplasty Market (US$ Million), 2021 - 2031
- FIG. 36 Africa Kyphoplasty Market (US$ Million), 2021 - 2031
- FIG. 37 Rest of Middle East and Africa Kyphoplasty Market (US$ Million), 2021 - 2031
